TC BioPharm (Holdings) PLC (TCBP)
0.6239
-0.01
(-0.94%)
USD |
NASDAQ |
Nov 22, 16:00
0.6199
0.00 (0.00%)
After-Hours: 20:00
TC BioPharm Cash from Operations (Quarterly): -3.055M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -3.055M |
| June 30, 2023 | -4.662M |
| March 31, 2023 | -3.539M |
| Date | Value |
|---|---|
| September 30, 2021 | -4.183M |
| September 30, 2020 | -2.469M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.662M
Minimum
Jun 2023
-2.469M
Maximum
Sep 2020
-3.582M
Average
-3.539M
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | -54.45M |
| Biodexa Pharmaceuticals PLC | -- |
| Verona Pharma PLC | -62.66M |
| NuCana PLC | -1.446M |
| Autolus Therapeutics PLC | -76.74M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0071M |
| Cash from Financing (Quarterly) | 1.183M |
| Free Cash Flow | -15.84M |
| Free Cash Flow Per Share (Quarterly) | -20.32 |
| Free Cash Flow Yield | -54.16K% |